Next |
home / stock / lexx / lexx message board
Subject | By | Source | When |
---|---|---|---|
Dont get too excited down 11% pre market | PotsandPans420 | investorshub | 05/19/2023 12:18:24 PM |
Hope Springs Eternal! | Shawking | investorshub | 05/19/2023 4:33:47 AM |
Be interesting to see if we see any | PotsandPans420 | investorshub | 05/18/2023 8:09:02 PM |
https://www.globenewswire.com/en/news-release/2021/02/23/2180141/28124/en/Global | Shawking | investorshub | 05/18/2023 7:45:25 PM |
Rush of price activity and volume more news coming? | codfather | investorshub | 05/18/2023 6:00:14 PM |
Thanks! | adam69 | investorshub | 05/18/2023 2:45:18 PM |
https://www.accesswire.com/755703/Lexarias-Hormone-Study-Shows-Significant-Enhan | Shawking | investorshub | 05/18/2023 2:37:44 PM |
volume 157k in less than an hour. | adam69 | investorshub | 05/18/2023 2:09:13 PM |
$LEXX MomentumIts trading up | Tech99989 | investorshub | 05/18/2023 5:34:00 AM |
$LEXX Good read | PotsandPans420 | investorshub | 05/17/2023 10:53:41 PM |
short squeeze signal | adam69 | investorshub | 05/15/2023 5:25:04 PM |
Ted Ohashi-Let's Toke Business | Shawking | investorshub | 05/15/2023 4:54:48 PM |
$LEXX Price trading up | Shawking | investorshub | 05/14/2023 3:23:28 PM |
$LEXX The trading | hdhick | investorshub | 05/14/2023 2:53:04 AM |
and the shorts continue | Shawking | investorshub | 05/14/2023 1:15:08 AM |
$LEXX MomentumIts now last trade up | PotsandPans420 | investorshub | 05/13/2023 2:30:43 PM |
oh yeah news for the day | all4weed | investorshub | 05/13/2023 5:11:37 AM |
Long and strong lets hope im right | Shawking | investorshub | 05/12/2023 9:03:24 AM |
short data if anyone is interested | PotsandPans420 | investorshub | 05/12/2023 8:57:51 AM |
what does this mean? | all4weed | investorshub | 05/12/2023 3:03:00 AM |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Company Name:
LEXX Stock Symbol:
NASDAQ Market:
Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful a...
Lexaria, a global innovator in drug delivery platforms, has added three new patents to its portfolio, bringing the total to 41 Two patents were awarded in the U.S., while the third was awarded in Japan, expiring in 2042 and 2041, respectively, if not extended Lexaria’s management plans...
(TheNewswire) Human Pilot Study #2 (GLP-1-H24-2) Approved Kelowna, British Columbia – TheNewswire – April 16, 2024 – Lexaria Bioscience Corp. (Nasdaq: LEXX; LEXXW) (the “Company” or “Lexaria”), a global innovator in drug d...